Industry Warns Of Cost-Shifting With Use Of Radiology Benefit Managers
This article was originally published in The Gray Sheet
Executive Summary
As policymakers consider the cost-saving prospects of requiring imaging scans to be pre-authorized by radiology benefit managers for Medicare coverage, industry is arguing that the policy may simply shift costs to providers.
You may also be interested in...
MedPAC Forwards More Ideas To Reduce Advanced Imaging Spending
The Medicare Payment Advisory Commission outlined four draft recommendations last week intended to either reduce payments for or control use of advanced imaging tools. Among the ideas: a prior authorization program specifically targeting physicians who order the most imaging scans.
ImmunoGen’s Elahere Data In Avastin-Naïve Ovarian Cancer Prompt Discussion About Earlier Use
The presenter on the MIRASOL study called the data “practice changing,” while the discussant cited Sutro’s STRO-002 as a potential option for patients with low folate receptor alpha expression.
ASCO - Servier’s Vorasidenib Puts The Brakes On Brain Cancer In INDIGO
Servier’s targeted therapy, vorasidenib, can effectively delay the need for more drastic treatment in patients with low-grade glioma, but increases in liver enzymes including two cases of Hy’s law have cast some shade over the INDIGO data.